Clinical trials in Jyvaskyla

35 clinical trials in Jyvaskyla, Finland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in FinlandKliinisetTutkimukset.fi

Jyvaskyla at a glance

clinical trials

Research sites2

Quick filters

35 trials in Jyvaskyla

Open in trial search

Chronic kidney disease

Recruiting

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:AZD5004
Sponsor:AstraZeneca AB

Contact Research Centre

Cardiovascular disorder+2

Recruiting

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:BI 690517
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Acute myocardial infarction

Recruiting

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational

Finland

Participants:18–64 years · 65+ years
Substances:Selatogrel
Sponsor:Viatris Innovation GmbH

Contact Research Centre

Coeliac disease

Recruiting

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Investigational

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Investigational

Finland

Participants:18–64 years · 65+ years
Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
Sponsor:Dr. Falk Pharma GmbH

Contact Research Centre

Dementia

Recruiting

Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older

Registered drug

Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older

Registered drug

Finland

Participants:65+ years · Healthy volunteers
Substances:Recombinant Varicella Zoster Virus Glycoprotein E
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Renal impairment

Recruiting

Study Comparing Intravenous Contrast CT with Non-Contrast CT for Patients with Acute Abdominal Pain and Reduced Kidney Function Using Iohexol

Registered drugNo placebo

Study Comparing Intravenous Contrast CT with Non-Contrast CT for Patients with Acute Abdominal Pain and Reduced Kidney Function Using Iohexol

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Iohexol
Sponsor:University Of Helsinki

Contact Research Centre

Intensive care

Recruiting

Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

Registered drugNo placebo

Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Dalteparin Sodium
Sponsor:Rigshospitalet

Contact Research Centre

Colorectal cancer metastatic+1

Recruiting

Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

Registered drugNo placebo

Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:HUS-Yhtymae

Contact Research Centre

Infantile spasms

Recruiting

Prevention of Infantile Spasms with Vigabatrin in High-Risk Children Under 1 Year Old: A Study for Patients with Tuberous Sclerosis or Large Vascular Brain Injury

Registered drugNo placebo

Prevention of Infantile Spasms with Vigabatrin in High-Risk Children Under 1 Year Old: A Study for Patients with Tuberous Sclerosis or Large Vascular Brain Injury

Registered drugNo placebo

Finland

Participants:0–17 years
Substances:Vigabatrin
Sponsor:HUS-Yhtymae

Contact Research Centre

Embolism venous

Recruiting

Study on Apixaban for Preventing Blood Clots in Patients Undergoing Abdominal, Gynecologic, and Urologic Surgery

Registered drugNo placebo

Study on Apixaban for Preventing Blood Clots in Patients Undergoing Abdominal, Gynecologic, and Urologic Surgery

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:HUS-Yhtymae

Contact Research Centre

Cardiac failure

Recruiting

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:Balcinrenone
Sponsor:AstraZeneca AB

Contact Research Centre

Coronary artery disease

Recruiting

Study Comparing Drug-Coated Balloon and Drug-Eluting Stents in Patients with Coronary Artery Disease at High Risk of Bleeding Using Acetylsalicylic Acid and Drug Combination

Registered drugNo placebo

Study Comparing Drug-Coated Balloon and Drug-Eluting Stents in Patients with Coronary Artery Disease at High Risk of Bleeding Using Acetylsalicylic Acid and Drug Combination

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Wellbeing Services County Of North Karelia Siun Sote

Contact Research Centre

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Jyvaskyla

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials focusing on atherosclerotic cardiovascular disease and stroke prevention. Studies evaluate new treatments for heart failure and examine the effectiveness of medications for preventing major cardiac events.

Stroke Prevention in Atrial Fibrillation
Heart Failure Management
Coronary Artery Disease Treatment

Advanced research includes evaluation of novel anticoagulants and cardiac interventions for high-risk patients.

02 Immunology and Vaccines

Clinical studies examining meningococcal vaccines and influenza protection in various age groups. Research focuses on vaccine safety and immune response in different populations.

Meningococcal Prevention
High-dose Influenza Vaccines
Pediatric Vaccine Studies

Emphasis on developing effective immunization strategies for vulnerable populations.

03 Metabolic and Digestive Disorders

Comprehensive research into obesity management and gastrointestinal conditions. Studies include innovative treatments for celiac disease and weight management approaches.

Obesity Treatment
Celiac Disease Management
Gastrointestinal Health

Trials explore both medication-based and surgical interventions for various metabolic conditions.

04 Oncology Studies

Advanced research in prostate cancer treatment and renal cell carcinoma management. Studies evaluate new therapeutic approaches and post-surgical treatments.

Prostate Cancer Therapy
Renal Cell Carcinoma Treatment
Cancer Immunotherapy

Focus on developing targeted therapies and improving treatment outcomes.

Back to Finland All countries